Functional Limitations in Systemic Lupus Erythematosus with Secondary Antiphospholipid Syndrome
Veterans with SLE and secondary APS experience substantial physical and occupational functional limitations affecting both basic and instrumental activities of daily living, with more than half reporting difficulty with housekeeping, laundry, and shopping, and over 40% experiencing limitations in bathing, dressing, and transferring. 1
Physical Functional Limitations
Basic Activities of Daily Living (BADLs)
- Transferring difficulties occur in 26.6% of SLE patients, representing the most common basic physical limitation 1
- Bathing limitations affect 25.3% of patients 1
- Dressing difficulties are reported by 24.4% of patients 1
- Continence problems occur in 22.0% of patients 1
- Overall, 43.8% of SLE patients report limitations in independently performing at least one basic ADL 1
Instrumental Activities of Daily Living (IADLs)
- Housekeeping is the most commonly affected activity, with 50.7% reporting difficulty 1
- Laundry tasks are problematic for 37.2% of patients 1
- Shopping activities are limited in 33.0% of patients 1
- More than half (56.2%) of SLE patients report limitations in at least one instrumental ADL 1
Neuropsychiatric Manifestations
Cognitive dysfunction is common and affects multiple domains including attention, visual memory, verbal memory, executive function, and psychomotor speed 2. While mild to moderate cognitive dysfunction is frequent, severe cognitive impairment resulting in functional compromise is relatively uncommon but should be confirmed by neuropsychological testing 2.
Cerebrovascular disease occurs in 50-60% of cases in the context of high disease activity, with ischemic stroke and transient ischemic attacks comprising over 80% of cerebrovascular events 2. The presence of antiphospholipid antibodies significantly increases stroke risk 2.
Seizures are common, with single seizures occurring frequently and recurrent seizures (epilepsy) developing in 12-22% of patients 2. Both generalized tonic-clonic seizures (67-88%) and partial complex seizures can occur 2.
Peripheral neuropathy often coexists with other neuropsychiatric manifestations and is diagnosed with electromyography and nerve conduction studies 2.
Musculoskeletal and Energy Limitations
- Fatigue is a major contributor to workplace activity limitations and overall work impairment 3
- Physical health limitations significantly impact presenteeism (difficulty performing work while present) 3
- Pain is strongly associated with both absenteeism and overall work impairment 3
Organ-Specific Limitations
Renal involvement is more severe in SLE-APS patients, with higher rates of chronic renal failure and progression to end-stage renal disease 4. Relapses of kidney disease occur in up to 45% of patients with a flare rate of 0.1-0.2 flares per patient per year 5.
Cardiovascular complications are more frequent in SLE-APS patients, who demonstrate higher rates of hypertension, dyslipidemia, and diabetes compared to SLE alone 4. Deep vein thrombosis and thrombotic events are more common in the APS population 6.
Visual impairment can result from optic neuritis (commonly bilateral in SLE) or ischemic optic neuropathy (usually unilateral, especially with antiphospholipid antibodies) 2. Antimalarial retinopathy occurs in 0.5% of patients on long-term hydroxychloroquine therapy 5.
Occupational Functional Limitations
Work Disability and Employment Impact
Work disability affects 23% of SLE patients cumulatively, with 52% of unemployed patients reporting lupus as the reason for not working 1, 7. Within the first year of diagnosis, only 47% of patients remain employed, while 7% are on disability and 7% are on sick leave 7.
Workplace Activity Limitations
Physical work tasks are cited as difficult by more than one-third of employed SLE patients 8. Among employed participants, 40% have medium to high workplace activity limitation scores 8.
Cognitive work tasks are reported as difficult by more than one-third of participants 8. Difficulties include problems with memory, attention, concentration, and word-finding 5.
Energy-related work activities are problematic for more than one-third of employed patients 8.
Work Productivity Impairment
- Absenteeism (time missed from work) averages 5.0% of work time 3
- Presenteeism (reduced productivity while at work) averages 28.5% 3
- Overall work impairment averages 31.3% 3
Risk Factors for Greater Occupational Limitations
Disease-related factors strongly associated with workplace limitations include higher disease activity (6.49-fold increased odds for IADL limitations and 7.35-fold for BADL limitations), greater fatigue, and poorer overall health status 1, 8.
Work context factors significantly associated with workplace activity limitations include lower job control, greater job strain, and working more than 40 hours per week 8.
Demographic and psychosocial factors include younger age at diagnosis, lower educational attainment, lower income, higher depression scores, and higher perceived stress 1, 3, 7.
Impact of Secondary Antiphospholipid Syndrome
SLE-APS patients exhibit more severe clinical profiles with higher frequencies of major organ involvement, including neuropsychiatric, cardiac, pulmonary, renal, and ophthalmological manifestations compared to SLE alone 4.
Greater damage accrual occurs in SLE-APS patients, with SLICC damage index scores of 1.9±2.2 compared to 1.1±1.6 in SLE alone 4. These patients also demonstrate more severe disease as measured by the Katz severity index (3.0±1.8 vs 2.6±1.6) 4.
Higher mortality rates are observed in SLE-APS patients compared to those with SLE alone or SLE with antiphospholipid antibodies without clinical APS 4.
Recurrent thrombotic events remain a significant concern despite adequate anticoagulation therapy, with deep vein thrombosis being more frequent in recently diagnosed APS patients 6.
Monitoring Considerations for Functional Assessment
Regular assessment intervals should occur every 6-12 months for patients with inactive disease, with emphasis on discussing occupational problems and quality of life 5.
Cognitive impairment assessment should evaluate memory, attention, concentration, and word-finding difficulties through clinical history 5. Formal neuropsychological testing should be considered when severe cognitive impairment resulting in functional compromise is suspected 2.
Cardiovascular risk factors require aggressive control in SLE-APS patients due to increased thrombotic risk, including management of hypertension, dyslipidemia, and diabetes 4, 9.